"International Eye Associates, located in Ormond Beach Florida with additional offices in Palm Coast, is a full service ophthalmology practice providing complete eye care for adults and children of all ages. Established by Dr. Mark Rubin in 1990, International Eye Associates has been associated with all of the area hospitals as well as the majority of the areas health insurance plans. Using the most modern technology available Dr. Rubin was the first surgeon in the area to implant the ReStor multi focal lens and was also the first surgeon to preform a toric intraocular implant to correct astigmatism during cataract surgery."

During the past decade, International Eye Associates, PA conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "International Eye Associates, PA" #1 sponsor was "Santen Inc." with 2 trials, followed by "Claris Biotherapeutics, Inc." with 1 trials sponsored, "Formosa Pharmaceuticals, Inc." with 1 trials sponsored, "Kala Pharmaceuticals, Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "International Eye Associates, PA" are "Cataract" (1 trials), "Dry Eye" (1 trials), "Dry Eye Syndromes" (1 trials), "Glaucoma and Ocular Hypertension" (1 trials) and "Keratoconjunctivitis Sicca" (1 trials). Many other conditions were trialed in "International Eye Associates, PA" in a lesser frequency.

Most popular intervention types in "International Eye Associates, PA" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "DE-117 Ophthalmic Solution" (2 trials), "0.005% Lacripep" (1 trials), "0.01% Lacripep" (1 trials), "APP13007, 0.05%" (1 trials) and "CSB-001 Ophthalmic Solution 0.1%" (1 trials). Other intervention names were less common.

The vast majority of trials in "International Eye Associates, PA" are 8 trials for "All" genders.

Currently, there are NaN active trials in "International Eye Associates, PA". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in International Eye Associates, PA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in International Eye Associates, PA, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".